SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

NuGene International, Inc. – ‘NT 10-Q’ for 3/31/17

On:  Monday, 5/15/17, at 6:04am ET   ·   Effective:  5/15/17   ·   For:  3/31/17   ·   Accession #:  1615774-17-2361   ·   File #:  1-37940

Previous ‘NT 10-Q’:  ‘NT 10-Q’ on 11/14/16 for 9/30/16   ·   Next & Latest:  ‘NT 10-Q’ on 11/14/22 for 9/30/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/15/17  NuGene International, Inc.        NT 10-Q     3/31/17    1:15K                                    S2 Filings LLC/FA

Notice of a Late Filing of a Form 10-Q   —   Form 12b-25
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NT 10-Q     Notification of Late Filing                         HTML     12K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

SEC FILE NUMBER

000 – 192997

NOTIFICATION OF LATE FILING

CUSIP NUMBER

67052F102

(Check One):

☐ Form 10-K    ☐ Form 20-F    ☐ Form 11-K
☒ Form 10-Q    ☐ Form 10-D    ☐ Form N-SAR    ☐ Form N-CSR

For Period Ended: March 31, 2017

Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
Transition Report on Form N-SAR
   

For the Transition Period Ended: _________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

NuGene International, Inc.
Full Name of Registrant


Former Name if Applicable

17912 Cowan, Suite A
Address of Principal Executive Office (Street and Number)

Irvine, California 92614
City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 

 

x (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
   
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
   
(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
   

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Registrant is unable to file its quarterly report on Form 10-Q within the prescribed time period because the Registrant requires additional time to finalize its financial statements for review by its independent accountant.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

 

  Keith A. Rosenbaum 949 851-4300
  (Name) (Area Code) (Telephone Number)

 

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).

☒ Yes ☐ No

   
(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof ?

Yes ☒ No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

NuGene International, Inc.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: 12 May 2017 By: /s/ M. Saeed Kharazmi
    M. Saeed Kharazmi
  Title: CFO

 

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘NT 10-Q’ Filing    Date    Other Filings
Filed on / Effective on:5/15/17
For Period End:3/31/17NT 10-K
 List all Filings 
Top
Filing Submission 0001615774-17-002361   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 11:53:19.1am ET